Atlas Trials

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Clinical trial NCT07406126 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07406126
Sponsor
Fernando Gómez Muñoz
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Start date
2026-02-01
Primary completion
2028-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.